Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitte Dam

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Gastroenterology and Hepatology|February 6, 2023
Reduced 3-year risk of hospital admission and mortality after 12-week resistance training of cirrhosis patients: A follow-up of a randomized clinical trialLuise Aamann, Gitte Dam, Peter Jepsen, et al.
Frontiers in Endocrinology|July 14, 2025
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapyTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
The Journal of Nutrition|June 7, 2013
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trialsLise L Gluud, Gitte Dam, Mette Borre, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 21, 2022
Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumoursTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
The Cochrane Database of Systematic Reviews|January 16, 2026
Branched-chain amino acids for people with cirrhosis and hepatic encephalopathyLuise Aamann, Neha Deshpande, Gitte Dam, et al.
Hepatology (Baltimore, Md.)|August 14, 2012
Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptakeGitte Dam, Susanne Keiding, Ole L Munk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2018
Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated ratsLuise Aamann, Rafael Ochoa-Sanchez, Mariana Oliveira, et al.
Hepatology (Baltimore, Md.)|January 3, 2013
Reply: To PMID 22886493Gitte Dam, Susanne Keiding, Ole L Munk, et al.
Journal of Neuroendocrinology|June 25, 2026
Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids"Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Neuroendocrinology|October 3, 2019
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine TumorsGitte Dam, Henning Grønbæk, Halfdan Sorbye, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Gastroenterology and Hepatology|February 6, 2023
Reduced 3-year risk of hospital admission and mortality after 12-week resistance training of cirrhosis patients: A follow-up of a randomized clinical trialLuise Aamann, Gitte Dam, Peter Jepsen, et al.
Frontiers in Endocrinology|July 14, 2025
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapyTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
The Journal of Nutrition|June 7, 2013
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trialsLise L Gluud, Gitte Dam, Mette Borre, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 21, 2022
Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumoursTobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, et al.
The Cochrane Database of Systematic Reviews|January 16, 2026
Branched-chain amino acids for people with cirrhosis and hepatic encephalopathyLuise Aamann, Neha Deshpande, Gitte Dam, et al.
Hepatology (Baltimore, Md.)|August 14, 2012
Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptakeGitte Dam, Susanne Keiding, Ole L Munk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2018
Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated ratsLuise Aamann, Rafael Ochoa-Sanchez, Mariana Oliveira, et al.
Hepatology (Baltimore, Md.)|January 3, 2013
Reply: To PMID 22886493Gitte Dam, Susanne Keiding, Ole L Munk, et al.
Journal of Neuroendocrinology|June 25, 2026
Response to "Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids"Tobias Stemann Lau, Patrick Soldath, Karina Stubkjær Rewitz, et al.
Neuroendocrinology|October 3, 2019
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine TumorsGitte Dam, Henning Grønbæk, Halfdan Sorbye, et al.
Pageof 5